GT
ACLS icon

Greenleaf Trust’s Axcelis ACLS Stock Holding History

Greenleaf Trust’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Buy
+1,804
New +$268K ﹤0.01% 636

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Greenleaf Trust's ACLS Position: Q2 2026 in Review

Greenleaf Trust opened a new position in Axcelis (ACLS) in Q2 2026: 1,804 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings.

441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Greenleaf Trust held 1,804 shares of Axcelis worth $342K as of Q2 2026.
  • Axcelis was a new Greenleaf Trust position in Q2 2026.
  • Axcelis made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #636 holding.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.